search
Back to results

Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening (IH062905)

Primary Purpose

Localized Lipodystrophy

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
1064 nm Nd:YAG laser
Sponsored by
University of California, Irvine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Localized Lipodystrophy focused on measuring Cellulite, Nd:YAG Laser

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Individuals, male or female, greater than 40 years of age.
  2. Moderate skin laxity in the arms, legs, abdomen, or neck.
  3. Subject is not overweight. Body Mass Index (B.M.I.) is ≤ 27.
  4. Subject has Fitzpatrick skin phototype I-IV.
  5. Subject is willing to participate in study and adhere to follow-up schedule.
  6. Subject is able to read and comprehend English.
  7. Subject has completed Informed Consent Form.

Exclusion Criteria:

  1. Subjects that have had liposuction or other surgical procedures (including mesotherapy) to remove fat in the treatment area during the past year.
  2. Subject is overweight (BMI > 27).
  3. Subject has known photosensitivity or history of ingesting medications known to induce photosensitivity in the previous 3 months.
  4. Subject has a personal or family history of keloid formation or scarring.
  5. Subject is pregnant or lactating.
  6. Subject has a history of uncontrolled diabetes and/or requires medication which may interfere with the study.
  7. Subjects with a known history of neuropathy.
  8. Subjects with a known history of a coagulopathy.
  9. Subject is unable or unwilling to comply with the study requirements
  10. Subject has pacemaker or metallic implants.
  11. Subject has Fitzpatrick skin type V and VI.
  12. Subject is mentally incompetent or a prisoner.

Sites / Locations

  • Beckman Laser Institute
  • UC Irvine Dermatology Clinical Research Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Candela DCD with cooling

Candela DCD without Cooling

Arm Description

Laser treatment with Candela DCD cooling which produces a cryogenic fluid that cools the epidermis prior to each laser pulse. Treatment will be conducted on either the left or the right thigh, which will also be randomly determined. The contra-lateral side will not be treated and will serve as a control. The laser system to be used in is Candela GentleYAG, a 1064nm Nd:YAG laser. This arm will receive a coolant during the laser procedure.

Laser treatment without cooling before each laser pulse. Treatment will be conducted on either the left or the right thigh, which will also be randomly determined. The contra-lateral side will not be treated and will serve as a control. The laser system to be used in is Candela GentleYAG, a 1064nm Nd:YAG laser. This arm will not receive a coolant during the laser procedure.

Outcomes

Primary Outcome Measures

Number of Participants With Mild to Moderate Reduction in Cellulite.
Nurnberger-Muller Scale : Stage 0: No dimpling. Stage 1: No dimpling. Stage 2: Dimpling spontaneously standing. Stage 3: Dimpling spontaneously standing and lying down. Texture Scale: Hard or Solid: Pinch test "firm folds and furrows." Adherent to deep planes. Not modified with lying versus standing position. Soft or Flaccid: Pinch test "spongy and floating folds and furrows." No adherence to deep planes. Not painful, flaccid. "Orange peel skin" appears spontaneously. Edematous: Doughy consistency. Pain and cramps. Signs of venous and lymphatic insufficiency "legs in boot/column". At the 6month follow-up, a blinded assessor ranked changes in cellulite appearance on subject's thighs according to the prior cellulite dimpling and texture criteria. Change in cellulite appearance was assessed on a scale of 0-3, with 0 as "no change" and 3 as "significant change." Improvement in cellulite appearance was characterized by an increase of one unit or more on this scale.
Average Extent of Reduction in Cellulite Appearance for Patients With Reported Mild to Moderate Cellulite Reduction.
At the 6 month follow-up, a blinded assessor ranked change in cellulite appearance on subject's thighs according to the prior cellulite dimpling and texture criteria. Change in cellulite appearance was assessed on a scale of 0-3, with 0 as "no change" and 3 as "significant change." Using this scale, the average reduction in cellulite appearance was calculated for each participant that experienced a mild to moderate reduction in cellulite appearance.

Secondary Outcome Measures

Full Information

First Posted
December 26, 2007
Last Updated
October 19, 2022
Sponsor
University of California, Irvine
Collaborators
Candela Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT00585715
Brief Title
Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
Acronym
IH062905
Official Title
Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Completed
Study Start Date
October 2006 (undefined)
Primary Completion Date
December 2009 (Actual)
Study Completion Date
January 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Irvine
Collaborators
Candela Corporation

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this research study is to evaluate effectiveness of a non-ablative (does not remove skin) treatment for cellulite (dimpled fat) in conjunction with skin tightening using the Candela GentleYAG laser.
Detailed Description
The objective of this investigation is to evaluate the effectiveness of a non-ablative treatment for skin laxity by increasing dermatofibrosis of the reticular dermis using the Candela GentleYAG laser. Treatment areas will be limited to the thighs. The primary objective is to assess the safety and efficacy of the laser for improvement in appearance of cellulite. The secondary objective is to assess the safety and efficacy of the laser with cooling and the laser without cooling for improvement in appearance of cellulite. This is an open label trial. Treatment will be conducted on either the left or the right thigh, which will be randomly determined. The contra-lateral side will not be treated and will serve as a control. A comparison of baseline photographs (prior to treatments) to photographs taken 1 and 3 months after the completion of treatments will be conducted. Photographic equipment and the protocol for photography will be consistent at each visit. Ultrasound may be taken at baseline and at the follow-up visits to evaluate flatness of cellulite and dermal fibrosis or enlargement of the reticular dermis. The circumference of the area to be treated will be measured with a tape measure, weight/height will be recorded and the Body Mass Index (BMI) will be calculated at baseline and follow-up visits. In addition, skin elasticity may be measured at the treatment areas at baseline and follow-up visits. The photographs, ultrasound and measurements will be taken using consistent procedures at each visit by viewing the baseline photograph and using landmarks such as freckles and birthmarks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Localized Lipodystrophy
Keywords
Cellulite, Nd:YAG Laser

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
22 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Candela DCD with cooling
Arm Type
Experimental
Arm Description
Laser treatment with Candela DCD cooling which produces a cryogenic fluid that cools the epidermis prior to each laser pulse. Treatment will be conducted on either the left or the right thigh, which will also be randomly determined. The contra-lateral side will not be treated and will serve as a control. The laser system to be used in is Candela GentleYAG, a 1064nm Nd:YAG laser. This arm will receive a coolant during the laser procedure.
Arm Title
Candela DCD without Cooling
Arm Type
Active Comparator
Arm Description
Laser treatment without cooling before each laser pulse. Treatment will be conducted on either the left or the right thigh, which will also be randomly determined. The contra-lateral side will not be treated and will serve as a control. The laser system to be used in is Candela GentleYAG, a 1064nm Nd:YAG laser. This arm will not receive a coolant during the laser procedure.
Intervention Type
Device
Intervention Name(s)
1064 nm Nd:YAG laser
Other Intervention Name(s)
Candela Gentle YAG Laser
Intervention Description
3 treatments at 3-5 week intervals Spot size: 10 - 18 mm diameter Fluence: 50 J/cm2 Laser pulse duration: 50 ms Rep. rate: Up to 2 Hz DCD cooling 0-50 ms
Primary Outcome Measure Information:
Title
Number of Participants With Mild to Moderate Reduction in Cellulite.
Description
Nurnberger-Muller Scale : Stage 0: No dimpling. Stage 1: No dimpling. Stage 2: Dimpling spontaneously standing. Stage 3: Dimpling spontaneously standing and lying down. Texture Scale: Hard or Solid: Pinch test "firm folds and furrows." Adherent to deep planes. Not modified with lying versus standing position. Soft or Flaccid: Pinch test "spongy and floating folds and furrows." No adherence to deep planes. Not painful, flaccid. "Orange peel skin" appears spontaneously. Edematous: Doughy consistency. Pain and cramps. Signs of venous and lymphatic insufficiency "legs in boot/column". At the 6month follow-up, a blinded assessor ranked changes in cellulite appearance on subject's thighs according to the prior cellulite dimpling and texture criteria. Change in cellulite appearance was assessed on a scale of 0-3, with 0 as "no change" and 3 as "significant change." Improvement in cellulite appearance was characterized by an increase of one unit or more on this scale.
Time Frame
6 month follow up
Title
Average Extent of Reduction in Cellulite Appearance for Patients With Reported Mild to Moderate Cellulite Reduction.
Description
At the 6 month follow-up, a blinded assessor ranked change in cellulite appearance on subject's thighs according to the prior cellulite dimpling and texture criteria. Change in cellulite appearance was assessed on a scale of 0-3, with 0 as "no change" and 3 as "significant change." Using this scale, the average reduction in cellulite appearance was calculated for each participant that experienced a mild to moderate reduction in cellulite appearance.
Time Frame
6 month follow up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Individuals, male or female, greater than 40 years of age. Moderate skin laxity in the arms, legs, abdomen, or neck. Subject is not overweight. Body Mass Index (B.M.I.) is ≤ 27. Subject has Fitzpatrick skin phototype I-IV. Subject is willing to participate in study and adhere to follow-up schedule. Subject is able to read and comprehend English. Subject has completed Informed Consent Form. Exclusion Criteria: Subjects that have had liposuction or other surgical procedures (including mesotherapy) to remove fat in the treatment area during the past year. Subject is overweight (BMI > 27). Subject has known photosensitivity or history of ingesting medications known to induce photosensitivity in the previous 3 months. Subject has a personal or family history of keloid formation or scarring. Subject is pregnant or lactating. Subject has a history of uncontrolled diabetes and/or requires medication which may interfere with the study. Subjects with a known history of neuropathy. Subjects with a known history of a coagulopathy. Subject is unable or unwilling to comply with the study requirements Subject has pacemaker or metallic implants. Subject has Fitzpatrick skin type V and VI. Subject is mentally incompetent or a prisoner.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kristen M Kelly, M.D.
Organizational Affiliation
University of California, Irvine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Beckman Laser Institute
City
Irvine
State/Province
California
ZIP/Postal Code
92697
Country
United States
Facility Name
UC Irvine Dermatology Clinical Research Center
City
Irvine
State/Province
California
ZIP/Postal Code
92697
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
Citation
Truitt, A., Echague, A., Zachary, C. Kelly K.M. Evaluation of the Candela 1064 nm Nd:YAG Laser for Cellulite and Skin Tightening. Presented at the American Society for Laser Medicine and Surgery Annual Meeting, 2007, Dallas, TX.
Results Reference
result
Links:
URL
http://www.bli.uci.edu/
Description
Beckman Laser Institute

Learn more about this trial

Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening

We'll reach out to this number within 24 hrs